로딩 중…
StockDiggingStockDigging

Yuyu Pharma, Inc.

000220· KOSPI
₩3,885-2.02%
2026-06-19

Price Chart

Yuyu Pharma, Inc.-15.08%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap66.17B KRW
Revenue143.52B KRW
Net Income2.14B KRW
Total Assets207.28B KRW
Net Assets142.56B KRW
Employees257
Value
P/E30.87x
P/B0.46x
PEG1.06x
P/S0.46x
EV/EBITDA254.44x
FCF Yield11.52%
Profitability
ROE1.50%
ROA1.03%
Op. Margin0.18%
Revenue Growth8.01%
Earnings Growth29.25%
Financial Health
Debt Ratio145.40%
Total Debt25.26B KRW
FCF7.62B KRW
Cash26.04B KRW
Current Ratio1.68x
Net Debt/EBITDA-3.03x
Dividend
Div. Yield2.90%
Div. Growth15.00%
Performance
1Y Return-15.08%
1M Return1.30%
From 52W High-23.82%
1Y MDD-23.69%
Trading
Volume148,252 shares
Foreign Own.2.19%
Per Share
EPS461 KRW
BPS7,146 KRW

Company Info

CEO 유원상, 박노용(각자대표)
Employees 257
Founded 1941
HQ 충청북도 제천시, KR

Established in 1941 as Yuhan Trading and listed on the securities market in 1975, the company is a pharmaceutical firm manufacturing and selling pharmaceuticals and health functional foods from its plant in Jecheon, Chungcheongbuk-do. It supplies specialized pharmaceuticals to domestic hospitals and clinics, operates a contract manufacturing business, and exports finished pharmaceuticals to various countries. With subsidiaries including YUYU Healthcare, YUYU Medicals, and YUYU VENTURES, the company is diversifying its business, including expansion into animal pharmaceuticals. The company is headquartered in Jecheon, Chungcheongbuk-do.